Cargando…
Adipocytes induce the resistance of ovarian cancer to carboplatin through ANGPTL4
The resistance of cancer cells to carboplatin restricts their efficacy in the clinical setting, and a solution to reverse the resistance is urgently required for the treatment of ovarian cancer. An increasing number of studies have found associations between obesity and the incidence, and mortality...
Autores principales: | Zhou, Songhui, Wang, Ruicheng, Xiao, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388553/ https://www.ncbi.nlm.nih.gov/pubmed/32705217 http://dx.doi.org/10.3892/or.2020.7647 |
Ejemplares similares
-
Cisplatin/carboplatin cross-resistance in ovarian cancer.
por: Gore, M. E., et al.
Publicado: (1989) -
TAZ Regulates the Cisplatin Resistance of Epithelial Ovarian Cancer Cells via the ANGPTL4/SOX2 Axis
por: Li, Caihong, et al.
Publicado: (2022) -
Genetic Mimicry Analysis Reveals the Specific Lipases Targeted by the ANGPTL3-ANGPTL8 Complex and ANGPTL4
por: Landfors, Fredrik, et al.
Publicado: (2022) -
ANGPTL4 Expression in Ovarian Granulosa Cells Is Associated With Polycystic Ovary Syndrome
por: Jiang, Qi, et al.
Publicado: (2022) -
ANGPTL4 is a potential driver of HCV-induced peripheral insulin resistance
por: Gomes, Diana, et al.
Publicado: (2023)